Astrazeneca Lp. v. Mylan Pharmaceuticals Inc.
Astrazeneca Lp. v. Mylan Pharmaceuticals Inc.
Opinion
NOTE: This disposition is nonprecedential.
United States Court of Appeals for the Federal Circuit ______________________ ASTRAZENECA LP, AKTIEBOLAGET DRACO, KBI INC., AND KBI-E INC., Plaintiffs-Appellants, v. MYLAN PHARMACEUTICALS INC., Defendant-Appellee. ____________________ 2011-1506 ______________________ Appeal from the United States District Court for the District of Delaware in No. 08-CV-0453, Chief Judge Gregory M. Sleet. ______________________ JUDGMENT ______________________ GEORGE F. PAPPAS, Covington & Burling LLP, of Washington, DC, argued for plaintiffs-appellants. With him on the brief were JEFFREY B. ELIKAN and MICHELLE L. MORIN.
NICOLE W. STAFFORD, Wilson Sonsini Goodrich & Rosati, of Austin, Texas, argued for defendant-appellee.
With her on the brief were ROBERT DELAFIELD; DAVID S.
STEUER and MATTHEW A. ARGENTI, of Palo Alto, California. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (RADER, Chief Judge, PLAGER and LOURIE, Circuit Judges).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT
April 9, 2012 /s/ Jan Horbaly Date Jan Horbaly Clerk
Case-law data current through December 31, 2025. Source: CourtListener bulk data.